静脉血栓形成的非炎症机制:一个未解之谜的全面解析
本文综述静脉血栓栓塞症(包括深静脉血栓形成和肺栓塞)超越炎症机制的多层面非炎症机制,涵盖血流动力学、内皮功能、血小板与微粒、代谢综合征与胰岛素抵抗、遗传突变、肠道菌群产物、内皮糖萼修饰、微小RNA、激素失衡及昼夜节律等,并据此提出未来治疗策略可能包括针对代谢、分子和系统性非炎症因素的干预。
要点
- 静脉血栓形成涉及血流动力学、内皮功能、血小板与微粒等非炎症机制。
- 代谢综合征、胰岛素抵抗、遗传突变、肠道菌群产物、内皮糖萼修饰、微小RNA、激素失衡及昼夜节律均与血栓风险相关。
- 未来治疗策略可能包括个性化风险分层、微生物组调节、内皮保护及时间治疗等干预。
核心结论
- 静脉血栓栓塞症是超越炎症机制的复杂病理过程,涉及分子、生理和系统层面的多重非炎症机制。
- 基于这些认识,未来治疗策略可能包括针对或至少考虑代谢、分子和系统性非炎症因素的多种干预。
研究设计与样本
- 本文为综述,整合分子、生理和系统层面的见解,全面审视静脉血栓形成的非炎症机制。
主要发现
- 血流动力学和内皮功能是血栓发展的关键调节因素。
- 血小板和微粒通过复杂的分子相互作用积极参与血栓形成,其作用超越传统炎症反应。
- 代谢综合征和胰岛素抵抗与血栓风险相关,显示代谢紊乱与深静脉血栓形成之间的复杂相互作用。
- 某些遗传突变使个体易患静脉血栓形成;肠道菌群产物或内皮糖萼修饰等先前未被重视的因素也起重要作用。
- 微小RNA和激素失衡等分子调节因素进一步说明静脉血栓形成的复杂机制;昼夜节律对血栓潜力有一定影响。
临床怎么用
- 未来治疗策略可能包括个性化风险分层、微生物组调节、内皮保护方法和基于时间治疗的治疗模式。
- 这些潜在方法旨在确保更有效和安全的血栓管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Venous thromboembolism, which includes deep vein thrombosis (DVT) and pulmonary embolism, represents a complex pathological process extending far beyond inflammatory mechanisms. This review comprehensively examines the multifaceted noninflammatory mechanisms underlying thrombosis development, integrating insights from molecular, physiological, and systemic levels. Blood flow dynamics and endothelial function are known to be critical regulators of thrombus development. Platelets and microparticles play important roles beyond conventional inflammatory responses, actively contributing to thrombus formation through intricate molecular interactions. Metabolic syndrome and insulin resistance are associated with thrombotic risk, demonstrating the complex interplay between metabolic disorders and DVT. Certain genetic mutations also predispose individuals to venous thrombosis. Emerging research has discovered the essential role of previously underappreciated factors such as products of gut microbiota or endothelial glycocalyx modifications. Molecular regulators such as microRNAs and hormonal disbalance further illustrate the complex mechanisms of venous thrombosis. Interestingly, circadian rhythms exhibit certain influence on thrombotic potential, introducing chronobiology as an emerging variable affecting the risk of thrombosis. On the basis of these insights, future therapeutic strategies may include various interventions targeting or at least considering metabolic, molecular, and systemic noninflammatory factors. Potential approaches include personalized risk stratification, microbiome modulation, endothelial protection approaches, and chronotherapy-based therapeutic modalities, which would ensure more efficient and safe thrombosis management.
引用
- Smith SRM, Morgan NV, Brill A, et al. Venous thrombosis unchained: Pandora's box of noninflammatory mechanisms. Blood Adv. 2025. PMID: 40117491. doi:10.1182/bloodadvances.2024014114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。